您当前所在位置:首页 > 宣传资料 > 新品上市
序号 标题 次数 作者 发布时间
72991 cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP 92 zyl 2024-12-19
72992 perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate 97 wyh 2024-12-19
72993 MC -Val-Cit, ADC试剂 125 kx 2024-12-19
72994 cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate 135 wyh 2024-12-19
72995 cas:159857-81-5 Mc-Val-Cit-PABC-PNP 94 zyl 2024-12-19
72996 MC-PEG4-va-PAB-Exatecan, ADC试剂 129 kx 2024-12-19
72997 cas:2101206-44-2 PY-DS-DMBUT-OPFP 116 zyl 2024-12-19
72998 Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate 56 wyh 2024-12-19
72999 SMCC-DM4(CAS号:1228105-52-9) 86 WYQ 2024-12-19
73000 NHS ester-PEG4-VC-PAB-Dxd, ADC试剂 185 kx 2024-12-19
73001 cas:53053-08-0,4-azidobenzoic acid N-hydroxysuccinimide ester 65 wyh 2024-12-19
73002 N3-Linker-Gefitinib,Gefitinib本身具有抗肿瘤活性 99 WYQ 2024-12-19
73003 Boc-Val-Cit-OH的介绍 92 zyl 2024-12-19
73004 mDPR-Val-Ala-PAB-MMAE, ADC试剂 106 kx 2024-12-19
73005 Boc-Val-Ala-PAB-OC2H5 | ADC Linker 99 zyl 2024-12-19
73006 cas:2259318-56-2,DBCO-PEG4-VC-PAB-DMAE-PNU159682, ADC试剂 102 kx 2024-12-19
73007 Mc-Dexamethasone,CAS号:1618096-56-2 111 WYQ 2024-12-19
73008 N3-PEG4-YPYDVPDYA-Doxorubicin,抗体偶联药物(ADC)的一部分 141 WYQ 2024-12-19
73009 DBCO-PEG4-VA-PAB-EDA-N-Ac-Calicheamicin,ADC定制 137 kx 2024-12-19
73010 N3-PEG4-DYKDDDD-Doxorubicin,抗体偶联药物(ADC)的一部分 122 WYQ 2024-12-19
73011 Azide-hex-vc-PAB-EDA-Biotin的介绍 118 zyl 2024-12-19
73012 Fmoc-PEG4-Val-Ala-PAB-PNP,具有类似的可降解性、生物相容性和定向运输特性 129 WYQ 2024-12-19
73013 DBCO-PEG4-vc-PAB (PEG2)- Duocarmycin SA,ADC定制 127 kx 2024-12-19
73014 Mal-Ala-Ala-PAB-PNP的介绍 122 zyl 2024-12-19
73015 Fmoc-PEG4-Val-Ala-PAB,合成抗体偶联药物(ADC) 93 WYQ 2024-12-19
73016 BODIPY-erythromycin,ADC定制 125 kx 2024-12-19
73017 MA-PEG4-Glu-Val-Cit-PAB-PNP 107 zyl 2024-12-19
73018 Boc-PEG4-Val-Ala-PAB-PNP,用于合成抗体偶联药物(ADC) 80 WYQ 2024-12-19
73019 Mc-Phe-Lys(Boc)-PAB-ADC分子 122 zyl 2024-12-19
73020 MC-GGFG-Dxd, ADC试剂 392 kx 2024-12-19
73021 Fmoc-Arg(boc)2-PAB-PNP-ADC抗体偶联药物 82 zyl 2024-12-19
73022 DBCO-PEG4-AcBu-Calicheamicin, ADC试剂 79 kx 2024-12-19
73023 Azido-PEG4-Val-Ala-PAB的介绍 77 zyl 2024-12-19
73024 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,ADC定制 63 wyh 2024-12-19
73025 OH-Glu-VC-PAB-MMAE, ADC试剂 128 kx 2024-12-19
73026 cas:663599-10-8,2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate,ADC定制 72 wyh 2024-12-19
73027 GGVA-PAB-PNU, ADC试剂 110 kx 2024-12-19
73028 132178-37-1,4-戊炔酸琥珀亚胺酯,ADC定制 176 wyh 2024-12-19
73029 cas:863971-53-3 Fmoc-Val-Cit-PAB-PNP 72 zyl 2024-12-19
73030 N3-PEG4-vc-PAB-Doxorubicin,药物递送系统的一部分 118 WYQ 2024-12-19
73031 cas:55750‐61‐3,N-SMP,马来酰亚胺基乙酸琥珀酰亚胺酯,ADC定制 94 wyh 2024-12-19
73032 MC-PEG4-EDA-PNU, ADC试剂 125 kx 2024-12-19
73033 cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 114 zyl 2024-12-19
73034 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) 100 WYQ 2024-12-19
73035 Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) 106 WYQ 2024-12-19
库存查询